Global Biosimilar by Type of Products (Human Growth Hormone, Granulocyte Colony-stimulating Factor (G-CSF), Insulin, Interferon, Erythropoietin, Immunomodulators, Monoclonal antibodies), By Application (Blood Disorders, Oncology, Growth Hormonal Deficiency, Chronic and Autoimmune Disease, Endocrinology, Nephrology) and by Geography – Opportunities & Forecast, 2018-2024

Published Date: | Number of Pages: 131 | Report Code: Biosimilar

(Get Free 25% Customization in this Report)

Licensing Options

Single-User License:
The report is used by the purchaser (One Individual) only

Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only

Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only

Global Biosimilar by Type of Products (Human Growth Hormone, Granulocyte Colony-stimulating Factor (G-CSF), Insulin, Interferon, Erythropoietin, Immunomodulators, Monoclonal antibodies), By Application (Blood Disorders, Oncology, Growth Hormonal Deficiency, Chronic and Autoimmune Disease, Endocrinology, Nephrology) and by Geography – Opportunities & Forecast, 2018-2024

$ 2,786.00$ 5,786.00

Clear
SKU: Biosimilar Categories: , ,